New U.S. Cancer Drug Prices Rise 53% In Five Years -report :

The annual price of a newly-launched cancer drug in the United States averaged $283,000 last year, a 53% increase from 2017, according to a new report from U.S.

Related Keywords

California , United States , America , Merck Kgaa Tepmetko , Celgene Idhifa , Stacie Dusetzina , Katie Porter , Joe Biden , Bristol Myers , Amgen Inc Lumakras , Nashville Vanderbilt University Medical Center , Drug Administration , Reuters , Representative Katie Porter , Inflation Reduction Act , Vanderbilt University Medical Center , Pharmaceutical Research , Takeda Pharmaceutical , Amgen Inc , National , ,